BIOM
VERY BADBiome Technologies Proposes Delisting from AIM, Going Private
The specialty chemicals company plans to delist from AIM and become a private firm, reducing liquidity and transparency for shareholders.
Biome Technologies
0.7500GBX
0.00%
Market Cap
386.67k
Volume
3.54M
2460% of avg
P/E Ratio
EPS (TTM)
Beta
2.31
Day Range
0.5550p - 0.9000p
52 Week Range
0.5550p0.7500p109.6000p
0.7500p
BIOM
NEUTRALBiome Technologies Secures Funding Facility to Support Operations
Bioplastics and RF technology company secures £750,000 funding facility to support operations
BIOM
BADBiome Technologies Faces Delays in Key Projects, Revises 2024 Guidance Downwards
The technology company has encountered component delivery issues, delaying the completion of key projects and leading to a downward revision of its 2024 financial guidance.
BIOM
BADBiome Technologies Warns of Lower Than Expected Revenues
The technology company faces production and regulatory issues at key customers, leading to lower than expected revenues in 2024.
BIOM
GOODBiome Technologies Appoints New Non-Executive Director
Bioplastics and RF technology firm Biome Technologies appoints new Non-Executive Director with industry experience.
BIOM
GOODBiome Technologies Secures Contract Upgrade for Analytical Equipment
Bioplastics and RF technology company secures contract upgrade for analytical equipment
BIOM
BADBiome Technologies Reports 35% Revenue Decline in Interim Results
The specialty chemicals firm reported a significant revenue decline of 35% in its interim results, citing production and regulatory challenges in its main division. Despite some positive developments in its secondary division, the company has revised down expectations for the year.
BIOM
NEUTRALBiome Technologies Shareholder Stake Diluted
Specialty chemicals company sees shareholder stake dilution
BIOM
NEUTRALMajor Shareholder Reduces Stake in Biome Technologies
Specialty chemicals company sees major shareholder reduce stake
BIOM
NEUTRALBiome Technologies Announces Change in Major Shareholding
Regulatory announcement from a specialty chemicals company, with a major shareholder reducing its stake.